Thrombocytopenia in Zetia - how severe and when it was recovered? (a real world drug study)

Summary:

We study how severe was Thrombocytopenia, when it was recovered, drug effectiveness, race, and more among people who take Zetia (ezetimibe). This phase IV clinical study is created by eHealthMe based on reports submitted to eHealthMe, and is updated regularly.

What is Zetia?

Zetia has active ingredients of ezetimibe. It is often used in high blood cholesterol. eHealthMe is studying from 49,112 Zetia users. Check the latest studies of Zetia.

What is Thrombocytopenia?

Thrombocytopenia (decrease of platelets in blood) is found to be associated with 2,796 drugs and 4,863 conditions by eHealthMe. Check the latest studies of Thrombocytopenia.



On Jun, 08, 2026

5 people who have Thrombocytopenia while taking Zetia were studied.

Could Zetia cause Thrombocytopenia?

Severity of Thrombocytopenia *:

  • least: 20 %
  • moderate: 60 %
  • severe: 20 %
  • most severe: 0.0 %

When people recovered from Thrombocytopenia *:

  • while on drug: 0.0 %
  • after off the drug: 0.0 %
  • not yet: 100 %

Effectiveness of Zetia *:

  • not at all: 0.0 %
  • somewhat: 0.0 %
  • moderate: 33.33 %
  • high: 66.67 %
  • very high: 0.0 %

Race of the people *:

  • African American, Non-Hispanic: 0.0 %
  • American Indian/Alaska Native: 0.0 %
  • Asian: 0.0 %
  • Hispanic: 20 %
  • Native Hawaiians/Pacific Islanders: 0.0 %
  • Two or more races: 0.0 %
  • White, Non-Hispanic: 80 %

Time on Zetia *:

  • < 1 month: 25 %
  • 1 - 6 months: 50 %
  • 6 - 12 months: 0.0 %
  • 1 - 2 years: 25 %
  • 2 - 5 years: 0.0 %
  • 5 - 10 years: 0.0 %
  • 10+ years: 0.0 %

Gender of people when taking Zetia *:

  • female: 80 %
  • male: 20 %

Age of people when taking Zetia *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 0.0 %
  • 50-59: 20 %
  • 60+: 80 %

Conditions people have *:

  1. Vitamin B12 Deficiency: 1 person, 20.00%
  2. Type Iv Hyperlipidaemia (abnormally elevated levels of any or all lipids and/or lipoproteins in the blood- type iv): 1 person, 20.00%
  3. Rickets (softening of bones): 1 person, 20.00%
  4. Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 1 person, 20.00%
  5. Pulmonary Hypertension (increase in blood pressure in the lung artery): 1 person, 20.00%
  6. Hypercalcemia (elevated calcium (ca+) level in the blood): 1 person, 20.00%
  7. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 1 person, 20.00%
  8. Cancer: 1 person, 20.00%

Other drugs people take besides Zetia *:

  1. Crestor: 3 people, 60.00%
  2. Vitamin D: 2 people, 40.00%
  3. Zegerid: 1 person, 20.00%
  4. Telmisartan: 1 person, 20.00%
  5. Probiotic: 1 person, 20.00%
  6. Magnesium Oxide: 1 person, 20.00%
  7. Ergocalciferol: 1 person, 20.00%
  8. Coq10: 1 person, 20.00%
  9. Cleocin Hydrochloride: 1 person, 20.00%
  10. Benicar Hct: 1 person, 20.00%

Other side effects people have besides Thrombocytopenia *:

  1. Splenomegaly (enlargement of spleen): 1 person, 20.00%
  2. Radicular Syndrome (pain and other symptoms such as numbness, tingling and weakness in the arms or legs): 1 person, 20.00%
  3. Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets): 1 person, 20.00%
  4. Numbness In Hands Or Feet: 1 person, 20.00%
  5. Numbness And Tingling (unusual prickling sensations): 1 person, 20.00%
  6. Leukopenia (less number of white blood cells in blood): 1 person, 20.00%
  7. Joint Pain: 1 person, 20.00%
  8. Back Disorder: 1 person, 20.00%
  9. Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 1 person, 20.00%
  10. Atherosclerosis (disorder of the arteries): 1 person, 20.00%

* Approximation only. Some reports may have incomplete information.

Do you take Zetia and have Thrombocytopenia?

Check whether Thrombocytopenia is associated with a drug or a condition

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Related studies

How the study uses the data?

The study is based on ezetimibe (the active ingredients of Zetia). Other drugs that have the same active ingredients (e.g. generic drugs) are considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: